Name
Purdue University Globle
NU577 NP II Clinical – Women’s Health Focus
Prof. Name
Date
Female adolescent health assessment is an important topic in advanced nursing education because it addresses pubertal development, preventive care, reproductive health, and psychosocial well-being. Key concepts include recognizing Tanner Stage II through breast budding and sparse pubic hair, identifying routine adolescent immunizations such as HPV and Tdap, recognizing normal squamous epithelial cells on Pap smears, and understanding the use of potassium hydroxide (KOH) preparation for fungal infections such as Candida. A complete assessment also considers menstrual history, sexual health, substance use, and the adolescent’s emotional and social needs.
This NU577 quiz study guide reviews essential concepts related to female adolescent health assessments, including puberty, immunization, cervical screening, vaginal infections, and patient-centered communication.
Female adolescent health assessments help healthcare providers monitor physical growth, pubertal development, reproductive health, and emotional well-being. Adolescence is a period of significant physiological and psychosocial change, making routine health assessments important for identifying developmental concerns and providing preventive care.
During a comprehensive adolescent visit, the healthcare provider evaluates the patient’s health history, performs an appropriate physical examination, reviews immunizations, and discusses behaviors that may affect long-term health. Confidential, respectful communication encourages adolescents to share concerns about menstruation, sexual health, substance use, and emotional well-being.
A comprehensive assessment generally includes:
Physical examination and Tanner staging.
Growth and pubertal development assessment.
Immunization history and preventive care.
Menstrual and reproductive health history.
Sexual health and STI risk assessment.
Behavioral and psychosocial screening.
Health education and anticipatory guidance.
The assessment should be appropriate for the adolescent’s age, developmental stage, and individual health needs. Healthcare providers should also explain confidentiality and its limits, including situations involving safety concerns or mandatory reporting requirements.
The Tanner Scale, also called Sexual Maturity Rating (SMR), is a clinical system used to describe physical changes during puberty. In female adolescents, breast development and pubic hair growth are the primary features evaluated.
Tanner staging helps healthcare providers determine whether pubertal development is progressing in an expected pattern. It is important to remember that adolescents do not all develop at the same rate, and individual variation is common.
Tanner Stage II is characterized by breast budding and the early appearance of pubic hair. It represents the beginning of visible breast development and is one of the first stages of female puberty.
Typical findings include:
Breast budding, also called thelarche, with a small mound of breast tissue beneath the nipple.
Enlargement of the areola.
Sparse, lightly pigmented, and usually straight pubic hair.
Early physical changes associated with pubertal maturation.
Full breast development is not expected during Tanner Stage II. More advanced breast development occurs during later Tanner stages.
Tanner Stage I represents the prepubertal stage, in which breast development has not yet begun. Tanner Stage II marks the onset of breast development, with breast budding and early pubic hair growth.
Healthcare providers should document the observed developmental stage and consider the adolescent’s overall growth pattern rather than relying on a single physical finding.
Immunization is an important part of preventive healthcare for adolescents. Vaccines protect against infections that can cause serious illness and help maintain protection established during childhood.
For a 13-year-old female, the healthcare provider should review the immunization record and determine which vaccines are due according to the current schedule, previous vaccination history, and individual medical circumstances.
Common vaccines reviewed during adolescent preventive visits include:
Human papillomavirus (HPV) vaccine: HPV vaccination helps prevent infections caused by HPV types associated with several cancers, including cervical cancer. Routine vaccination is recommended during early adolescence, and catch-up vaccination may be appropriate for eligible individuals.
Tetanus, diphtheria, and pertussis (Tdap) vaccine: Tdap is routinely recommended at 11–12 years of age. A 13-year-old who has not received the recommended dose should be assessed for catch-up vaccination.
Meningococcal vaccines: Meningococcal vaccination is part of routine adolescent preventive care. The recommended schedule depends on the vaccine type and the patient’s age and circumstances.
Hepatitis B vaccine: If the hepatitis B vaccination series is incomplete, the healthcare provider should review the record and recommend the appropriate remaining doses.
Influenza vaccine: Annual influenza vaccination is recommended for eligible adolescents.
HPV and Tdap are particularly important concepts in adolescent immunization questions. However, vaccination recommendations should always be based on the current CDC schedule rather than age alone.
No. There is no approved HIV vaccine available for routine clinical immunization. HIV prevention instead involves evidence-based strategies such as education, risk reduction, appropriate testing, and preventive medications when indicated.
For nursing examinations, it is important to distinguish established vaccines, such as HPV and Tdap, from preventive measures used for infections for which no approved vaccine exists.
A Pap smear, also called a Pap test, is a cervical screening procedure used to identify abnormal cervical cells that may indicate precancerous changes or cancer. Cervical screening recommendations depend on age, prior results, and individual risk factors.
Pap testing is not routinely recommended for every adolescent. Screening recommendations should be followed according to current guidelines.
Normal Pap smear findings may include squamous epithelial cells from the cervix. These cells are part of the normal cervical epithelium and may be observed in a satisfactory specimen.
A normal result indicates that no abnormal cervical cell changes were identified by the test. It does not necessarily mean that every possible infection or gynecological condition has been excluded.
Abnormal findings may require further evaluation depending on the type of abnormality and the patient’s age and screening history. Examples include atypical squamous cells and other abnormal cytological findings.
When reviewing Pap smear questions, distinguish between:
Normal squamous epithelial cells.
Abnormal cervical cytology.
HPV testing.
Cervical cancer screening recommendations.
Follow-up of abnormal screening results.
A Pap smear is primarily used to assess cervical cell changes. It should not be confused with a general test for vaginal infections.
Potassium hydroxide (KOH) preparation is a microscopic diagnostic test used to identify fungal organisms in clinical specimens. In gynecological assessment, it is commonly associated with the diagnosis of vulvovaginal candidiasis.
KOH helps dissolve cellular debris and makes fungal structures easier to visualize under a microscope.
KOH preparation is commonly used to identify fungal infections, including:
Candida vulvovaginitis: A yeast infection that may cause vulvar itching, irritation, redness, and abnormal vaginal discharge. Microscopic examination may reveal budding yeast or pseudohyphae.
Dermatophyte infections: Fungal skin infections, such as tinea, may also be evaluated using KOH preparation. Depending on the specimen, fungal hyphae may be visible.
In a nursing quiz, a patient with vulvovaginal itching and suspected Candida infection may have a KOH preparation ordered to look for fungal elements.
KOH preparation is particularly useful for suspected fungal infections. Other diagnostic tests may be used for different conditions.
For example, a wet mount examination may identify motile trichomonads or clue cells, while vaginal pH and additional laboratory testing can support the evaluation of other causes of vaginitis.
A positive KOH preparation supports the diagnosis of a fungal infection, but clinical findings and other laboratory results may also be needed.
Adolescent healthcare should address more than physical development. Sexual health, mental well-being, family relationships, substance use, and safety are important components of a comprehensive nursing assessment.
Healthcare providers should create a respectful and confidential environment. When appropriate, part of the visit should occur privately with the adolescent to encourage honest communication and identify concerns that may not be discussed in front of parents or guardians.
A healthcare provider may ask questions such as:
Menstrual history: “When was your last menstrual period?” This helps assess menstrual patterns, pregnancy possibility, and concerns such as irregular bleeding or dysmenorrhea.
Sexual history: “Have you ever been sexually active?” This supports individualized STI screening, pregnancy assessment, and contraceptive counseling.
Tobacco use: “Do you smoke or use tobacco products?” This helps identify tobacco exposure and the need for prevention or cessation education.
Alcohol consumption: “Do you consume alcohol?” This provides an opportunity to assess alcohol use and related safety concerns.
Additional questions may address vaping, other substances, mood, relationships, safety, and experiences of coercion or abuse when clinically appropriate.
Sexual history screening is an important part of adolescent preventive healthcare. Asking respectful, age-appropriate questions allows healthcare providers to identify risks and offer individualized education.
A sexual history should be taken without judgment and with attention to privacy. The information collected helps determine which preventive services may be appropriate.
Sexual health assessment can guide:
STI testing and treatment.
Pregnancy testing when indicated.
Contraceptive counseling.
HPV vaccination recommendations.
Reproductive health education.
Counseling about safer sex practices.
Healthcare providers should avoid assuming sexual activity based on age, appearance, or relationship status. Questions should be open-ended and tailored to the patient’s needs.
The following concepts are important when reviewing female adolescent health assessment questions:
Tanner Stage II includes breast budding and sparse pubic hair.
Tanner Stage I is the prepubertal stage without breast development.
HPV and Tdap are important vaccines reviewed during adolescent preventive visits.
Meningococcal, hepatitis B, and annual influenza vaccination should also be considered according to current recommendations.
There is no approved HIV vaccine for routine clinical use.
Normal Pap smear findings may include squamous epithelial cells.
KOH preparation is commonly used to identify fungal organisms, including Candida.
Menstrual history, sexual activity, tobacco use, and alcohol consumption are important areas of adolescent assessment.
Confidential and patient-centered communication supports effective adolescent healthcare.
Tanner Stage II is the beginning of visible female pubertal development. It is characterized by breast budding, areolar enlargement, and sparse pubic hair.
Common adolescent vaccines include HPV, Tdap, meningococcal vaccines, and annual influenza vaccination. Hepatitis B vaccination should be reviewed if the series is incomplete. Recommendations depend on the current immunization schedule and vaccination history.
Squamous epithelial cells are a normal finding in a satisfactory cervical specimen. Pap testing is used to assess cervical cell changes, including precancerous abnormalities.
KOH preparation is used to identify fungal organisms. In female reproductive health assessment, it is commonly associated with Candida vulvovaginitis.
Menstrual history helps healthcare providers evaluate reproductive health, identify abnormal bleeding patterns, assess pregnancy possibility when relevant, and recognize concerns that may require further evaluation.
Questions about tobacco and alcohol use help identify health risks and provide opportunities for prevention, counseling, and early intervention.
American Academy of Pediatrics. (2023). Adolescent immunization schedule. https://www.aap.org/en/patient-care/immunizations/
Berkowitz, C. D. (2021). Pediatrics: A primary care approach (6th ed.). American Academy of Pediatrics.
Centers for Disease Control and Prevention. (2024). Sexually transmitted infections treatment guidelines. https://www.cdc.gov/std/treatment/
Centers for Disease Control and Prevention. (2025). Child and adolescent immunization schedule. https://www.cdc.gov/vaccines/schedules/
National Cancer Institute. (2024). Pap and HPV testing. https://www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet
World Health Organization. (2024). Adolescent health. https://www.who.int/health-topics/adolescent-health
